SNP | risk variant | European Americans non-diabetic [10] | European Americans [16] | Spanish Caucasians [11] | European isolated cohorts [5] | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Microsa | Visb | ERFc | Meta-analysis of Micros, VIS, ERF | ||||||||||||
eGFR< 60 ml/min | FSGS | eGFR< 60 ml/min | serum creatinine increment (mg/dl) | ||||||||||||
OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | b# (SE) | p | b# (SE) | p | b# (SE) | p | b# (SE) | p | ||
rs3752462 | T | – | 2.42 (1.17–5.04) | .01 | 1.99 (1.20–3.31) | .007 | – | – | – | – | |||||
rs11089788 | C | – | – | – | −0.0108 (0.0061) | .0782 | −0.0204 (0.0143) | .1555 | −0.0109 (0.0075) | .1465 | −0.0118 (0.0045) | .0089 | |||
rs5756168 | C | – | – | – | 0.0284 (0.0097) | .0034 | −0.0436 (0.0255) | .0875 | 0.0144 (0.0108) | .1839 | 0.0173 (0.0069) | .0127 | |||
rs2239784 | T | – | – | – | 0.0309 (0.0142) | .0294 | −0.0069 (0.0269) | .7983 | 0.0158 (0.0172) | .3560 | −0.0112 (0.0101) | .2674 | |||
rs136211 | A | – | – | – | −0.0021 (0.0067) | .7502 | −0.0406 (0.0162) | .0123 | 0.01240.0075) | .1009 | 0.0004 (0.0048) | .9414 | |||
rs4821480 | G | 1.44 (1.15–1.80) | 0.001 | 9.73 (1.07–463) | .02 | – | – | – | – | – |